FRAMINGHAM, Mass., June 03, 2025 - Definitive Healthcare Corp. (Nasdaq: DH) has announced the approval of an inducement award for its newly appointed Chief Commercial Officer, Tina Hannagan. The award, granted by the Human Capital Management and Compensation Committee of the company's Board of Directors, consists of 830,565 time-based restricted stock units (RSUs), effective June 1, 2025. The award was individually negotiated and aligns with Nasdaq Listing Rule 5635(c)(4), serving as an inducement material to Ms. Hannagan's employment commencement. Under the terms of Definitive Healthcare's 2023 Inducement Plan, 25% of the RSUs are set to vest on June 1, 2026, with the remaining RSUs vesting in quarterly installments of 6.25% over the following three years, contingent upon Ms. Hannagan's continued employment with the company.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。